NCT01479361View on ClinicalTrials.gov

Antiretroviral Drug Interaction Study in Volunteers With HIV

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

February 20, 2014

Study Completion Date

February 20, 2014

Conditions
HIVPCPToxoplasmosis
Interventions
DRUG

Atovaquone 750 mg twice daily

DRUG

Atovaquone 1500 mg twice daily

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT01479361 - Antiretroviral Drug Interaction Study in Volunteers With HIV | Biotech Hunter | Biotech Hunter